World Health Organization. International classification of functioning, disability and health. Geneva: World Health Organization; 2001.
Baum C, Edwards D. Activity Card Sort test kit. St Louis MO: Washington University; 2001.
Baum CM, Christiansen CH, Bass JD, editors. Occupational therapy: performance, participation, and well-being. Thorofare: Slack; 2015.
Engel-Yeger B, Tse T, Josman N. Scoping review: the trajectory of recovery of participation outcomes following stroke. Behav Neurol. 2018;5472018. https://doi.org/10.1155/2018/5472018.
Davies G, Greenwood K. A meta-analytic review of the relationship between neurocognition, metacognition and functional outcome in schizophrenia. J Ment Health. 2018;29(5):496–505.
Kaizerman-Dinerman A, Roe D, Josman N. An efficacy study of a metacognitive group intervention for people with schizophrenia. Psychiatry Res. 2018;270:1150–6.
Ventura J, Hellemann GS, Thames AD, et al. Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis. Schizophr Res. 2009;113(2–3):189–99.
Flavell JH. Cognitive development. 2nd ed. Englewood Cliffs NJ: Prentice Hall; 1985.
American Occupational Therapy Association. Occupational therapy practice framework: Domain and process. 4th ed. Am J Occup Ther 2020; doi:https://doi.org/10.5014/ajot.2020.74S2001.
Toglia J, Kirk U. Understanding awareness deficits following brain injury. NeuroRehabil. 2000;15(1):57–70.
Josman N. The dynamic interactional model in schizophrenia. In: Katz N, editor. Cognition, occupation, and participation across the lifespan: neuroscience, neurorehabilitation, and models of intervention in occupational therapy. Bethesda: AOTA Press; 2011. p. 203–21.
Josman N. Regev S Dynamic interactional model in severe mental illness: a metacognitive and strategy-based intervention. In: Katz N, Toglia J, editors. Cognition, occupation, and participation across the lifespan: neuroscience, neurorehabilitation, and models of intervention in occupational therapy. Bethesda: AOTA Press; 2018. p. 387–403.
Katz N, Hartman-Maeir A. Activity Card Sort: Israeli version. Jerusalem: Hebrew University; 2001.
Hillis JD, Leonhardt BL, Vohs JL, et al. Metacognitive reflective and insight therapy for people in early phase of a schizophrenia spectrum disorder. J Clin Psychol. 2015;71(2):125–35.
Hasson-Ohayon I, Avidan-Msika M, Mashiach-Eizenberg M, et al. Metacognitive and social cognition approaches to understanding the impact of schizophrenia on social quality of life. Schizophr Res. 2015;161(2–3):386–91.
Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–76.
MacBeth A, Gumley A, Schwannauer M, et al. Metacognition, symptoms and premorbid functioning in a first episode psychosis sample. Compr Psychiatry. 2014;55(2):268–73.
Emsley R, Chiliza B, Asmal L, et al. The concepts of remission and recovery in schizophrenia. Curr Opin Psychiatry. 2011;24(2):114–21.
Lipskaya-Velikovsky L, Jarus T, Easterbrook A, et al. Participation in daily life of people with schizophrenia in comparison to the general population. Can J Occup Ther. 2016;83(5):297–305.
Greenwood KE, Morris R, Sigmundsson T, et al. Executive functioning in schizophrenia and the relationship with symptom profile and chronicity. J Int Neuropsychol Soc. 2008;14(5):782–92. https://doi.org/10.1017/S1355617708081198.
Lysaker PH, Warman DM, Dimaggio G, et al. Metacognition in schizophrenia: associations with multiple assessments of executive function. J Nerv Ment Dis. 2008;196(5):384–9.
Rocca P, Montemagni C, Castagna F, et al. Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry. 2009;33(2):373–9.
Green MF, Harvey PD. Cognition in schizophrenia: past, present, and future. Schizophr Res. 2014;1(1):e1–9.
Bowie CR, Depp C, McGrath JA, et al. Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder. Am J Psychiatry. 2010;167(9):1116–24.
Lysaker PH, Gagen E, Wright A, et al. Metacognitive deficits predict impaired insight in schizophrenia across symptom profiles: a latent class analysis. Schizophr Bull. 2019;45(1):48–56.
Harvey PD, Strassnig M. Predicting the severity of everyday functional disability in people with schizophrenia: cognitive deficits, functional capacity, symptoms, and health status. World Psychiatry. 2012;11(2):73–9.
Lysaker PH, Minor KS, Lysaker JT, et al. Metacognitive function and fragmentation in schizophrenia: relationship to cognition, self-experience and developing treatments. Schizophr Res. 2020;19:100142.
Lipskaya L, Jarus T, Kotler M. Influence of cognition and symptoms of schizophrenia on IADL performance. Scand J Occup Ther. 2011;18(3):180–7.
Nuechterlein KH, Ventura J, Subotnik KL, et al. Developing a cognitive training strategy for first-episode schizophrenia: integrating bottom-up and top-down approaches. Am J Psychiatr Rehabil. 2014;17(3):225–53.
Roth RM, Gioia GA, Isquith PK. BRIEF-A: Behavior Rating Inventory of Executive Function-adult version. Lutz: Psychological Assessment Resources; 2005.
Rotenberg-Shpigelman S, Rapaport R, Stern A, et al. Content validity and internal consistency reliability of the Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) in Israeli adults with attention-deficit/hyperactivity disorder. Isr J Occup Ther. 2008;7(2):77–96.
Toglia J. Weekly Calendar Planning Activity. Bethesda: AOTA Press; 2015.
Lahav O, Ben-Simon A, Inbar-Weiss N, et al. Weekly Calendar Planning Activity for university students: comparison of individuals with and without ADHD by gender. J Atten Disord. 2018;22(4):368–78.
Berger I, Grossman E, Maeir A, et al. Weekly Calendar Planning Activity (WCPA): validating a measure of functional cognition for adolescents with ADHD. Am J Occup Ther. 2019;73(4Supp1):7311515260P1.
Chu E, Nagata R, Tobey P, et al. The calendar study: reliability and validity of the Weekly Calendar Planning Activity (WCPA) to assess executive function (EF) in college students. Am J Occup Ther. 2020;74(4Supp1):7411500051p1.
Katz N, Karpin H, Lak A, et al. Participation in occupational performance: reliability and validity of the Activity Card Sort. OTJR. 2003;23(1):10–7.
Rollins AL, Bond GR, Lysaker PH, et al. Coping with positive and negative symptoms of schizophrenia. Am J Psychiatr Rehabil. 2010;13(3):208–23.
Brazo P, Delamillieure P, Morello R, et al. Impairments of executive/attentional functions in schizophrenia with primary and secondary negative symptoms. Psychiatry Res. 2005;133(1):45–55.
Leutwyler H, Hubbard E, Jeste D, et al. Association between schizophrenia symptoms and neurocognition on mobility in older adults with schizophrenia. Aging Ment Health. 2014;18(8):1006–12.
Josman N, Elbaz-Schenirderman A, Klinger E, et al. Using virtual reality to evaluate executive functioning among persons with schizophrenia: a validity study. Schizophr Res. 2009;115(2–3):270–7.
Chaytor N, Schmitter-Edgecombe M, Burr R. Improving the ecological validity of executive functioning assessment. Arch Clin Neuropsychol. 2006;21(3):217–27.
Maeir A, Krauss S, Katz N. Ecological validity of the Multiple Errands Test (MET) on discharge from neurorehabilitation hospital. OTJR. 2011;31(1):S38–46.
Kaizerman-Dinerman A, Josman N, Roe D. The use of cognitive strategies among people with schizophrenia: a randomized comparative study. Open J Occup Ther. 2019;7(3):1–12.
Toglia J. The dynamic interactional model and the multicontext approach. In: Katz N, Toglia J, editors. Cognition, occupation, and participation across the lifespan: neuroscience, neurorehabilitation, and models of intervention in occupational therapy. Bethesda: AOTA Press; 2018. p. 355–85.
Toglia J, Foster ER. The multicontext approach to cognitive rehabilitation: a metacognitive strategy intervention to optimize functional cognition. Columbus: Gatekeeper Press; 2021.
Kring AM, Gur RE, Blanchard JJ, Horan WP, Reise SP. The Clinical Assessment Interview for Negative Symptoms (CAINS): Final development and validation. Am J Psychiatry. 2013;170:165–72.